HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc Diederich Selected Research

aplysinopsin

5/2021Anti-Leukemic Properties of Aplysinopsin Derivative EE-84 Alone and Combined to BH3 Mimetic A-1210477.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc Diederich Research Topics

Disease

105Neoplasms (Cancer)
01/2022 - 10/2003
34Leukemia
12/2021 - 10/2003
19BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2021 - 01/2007
13Inflammation (Inflammations)
01/2020 - 04/2004
11Carcinogenesis
01/2020 - 10/2003
6Breast Neoplasms (Breast Cancer)
01/2021 - 09/2010
6Prostatic Neoplasms (Prostate Cancer)
01/2016 - 03/2010
5Necrosis
01/2020 - 10/2003
5Anemia
01/2019 - 08/2006
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 11/2015
3Myeloid Leukemia (Leukemia, Myelocytic)
05/2021 - 01/2020
3Lung Neoplasms (Lung Cancer)
01/2018 - 07/2013
3Neoplasm Metastasis (Metastasis)
01/2018 - 03/2010
2Multiple Myeloma
01/2021 - 08/2006
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019 - 02/2014
2Lymphoma (Lymphomas)
12/2015 - 01/2014
2Hematologic Neoplasms (Hematological Malignancy)
01/2014 - 10/2010
2Pathologic Processes
07/2013 - 06/2012
2Heart Failure
05/2013 - 01/2011
2Acute Erythroblastic Leukemia (Erythroleukemia)
03/2009 - 05/2006

Drug/Important Bio-Agent (IBA)

15CurcuminIBA
10/2015 - 10/2003
12Pharmaceutical PreparationsIBA
01/2022 - 09/2004
12NF-kappa B (NF-kB)IBA
01/2017 - 10/2003
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 04/2004
10Biological ProductsIBA
01/2018 - 02/2010
9Proteins (Proteins, Gene)FDA Link
05/2021 - 10/2003
8AntioxidantsIBA
01/2018 - 04/2004
7Imatinib Mesylate (Gleevec)FDA Link
05/2021 - 12/2018
7EnzymesIBA
01/2019 - 04/2004
7DNA (Deoxyribonucleic Acid)IBA
01/2019 - 02/2011
7Transcription Factors (Transcription Factor)IBA
11/2014 - 10/2003
6Glutathione Transferase (Glutathione S-Transferase)IBA
01/2014 - 10/2003
5Histone Deacetylases (Histone Deacetylase)IBA
01/2020 - 09/2013
5DecitabineFDA Link
01/2019 - 02/2011
5CytokinesIBA
01/2019 - 11/2008
5Cytostatic AgentsIBA
12/2018 - 07/2013
4Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2011
4Histone Deacetylase InhibitorsIBA
01/2020 - 08/2014
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2015 - 01/2010
4ChalconesIBA
09/2014 - 04/2006
3bcr-abl Fusion ProteinsIBA
01/2020 - 01/2008
3Therapeutic UsesIBA
01/2020 - 12/2015
3Histones (Histone)IBA
02/2018 - 09/2013
3Sirtuin 1IBA
02/2018 - 11/2014
3Cardiac GlycosidesIBA
01/2018 - 01/2011
3Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 01/2016
3FlavonoidsIBA
07/2016 - 09/2014
3Reactive Oxygen Species (Oxygen Radicals)IBA
07/2014 - 04/2004
3Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2014 - 10/2003
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
11/2011 - 12/2010
3Glutathione (Reduced Glutathione)IBA
02/2009 - 09/2004
2indoleIBA
11/2021 - 05/2021
2CaspasesIBA
10/2020 - 02/2014
2Tyrosine Kinase InhibitorsIBA
10/2020 - 01/2020
2Matrix Metalloproteinases (MMPs)IBA
01/2020 - 01/2015
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2020 - 06/2014
2MethyltransferasesIBA
01/2019 - 02/2014
2CoumarinsIBA
01/2019 - 01/2018
2Azacitidine (5 Azacytidine)FDA Link
01/2019 - 02/2014
2Hormones (Hormone)IBA
06/2018 - 05/2015
2AlkaloidsIBA
02/2018 - 04/2016
2TubulinIBA
02/2018 - 12/2017
2Adenosine Triphosphatases (ATPase)IBA
11/2017 - 05/2013
2LactonesIBA
01/2017 - 04/2006
2cyclohexanoneIBA
01/2017 - 09/2010
2Androgen Receptors (Androgen Receptor)IBA
01/2016 - 03/2010
2PolyphenolsIBA
10/2015 - 10/2013
2Celecoxib (Celebrex)FDA Link
10/2015 - 11/2011
2ThiazolidinedionesIBA
05/2015 - 11/2014
2Apoptosis Regulatory ProteinsIBA
01/2015 - 11/2012
2ErythropoietinFDA Link
11/2014 - 07/2011
2aclacinomycinsIBA
11/2014 - 03/2009
2KetonesIBA
09/2014 - 09/2011
2Etoposide (VP 16)FDA LinkGeneric
01/2014 - 04/2012
2Cisplatin (Platino)FDA LinkGeneric
12/2013 - 04/2012
2Phosphotransferases (Kinase)IBA
10/2013 - 01/2007
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2013 - 04/2011
2ChromatinIBA
11/2012 - 06/2011
2MicroRNAs (MicroRNA)IBA
06/2012 - 10/2011
2AndrogensIBA
06/2012 - 03/2011
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2012 - 03/2009
2Sulfur Compounds (Compounds, Sulfur)IBA
03/2011 - 05/2009
2UNBS 1450IBA
01/2011 - 07/2009
2MelatoninIBA
12/2010 - 08/2009
1sulforaphaneIBA
12/2021
1QuinazolinesIBA
11/2021
1aplysinopsinIBA
05/2021
1A-1210477IBA
05/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021
1asciminibIBA
01/2021
1Lactic Acid (Lactate)FDA LinkGeneric
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1Methylcellulose (BFL)IBA
10/2020
1Histone Deacetylase 6IBA
01/2020
1fms-Like Tyrosine Kinase 3IBA
01/2020

Therapy/Procedure

26Therapeutics
01/2022 - 07/2009
9Drug Therapy (Chemotherapy)
07/2016 - 06/2005
8Chemoprevention
03/2014 - 06/2005
5Immunotherapy
01/2022 - 03/2010
3Traditional Medicine (Folk Remedies)
09/2014 - 04/2006